Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Wendy Dixon


  • Director at Incyte Corp (INCY), 2019-07-02
  • Director at Sesen Bio Inc. (SESN), 2019-06-21
  • Director at Voyager Therapeutics Inc. (VYGR), 2019-06-17
  • Director at Bluebird Bio Inc. (BLUE), 2019-06-10
  • Director at Alkermes Plc. (ALKS), 2019-05-23
  • Director at Orexigen Therapeutics Inc. (OREX), 2015-06-10
  • Director at Furiex Pharmaceuticals Inc. (FURX), 2014-07-07
  • Director at Ardea Biosciences Inc. (RDEA), 2012-06-20
  • Director at Alkermes Inc (ALKS), 2011-09-20
  • Director at Dentsply International Inc (XRAY), 2010-07-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALKS $47.37 1,600 Director 1,600 2014-03-11 Filing
INCY $13.40 3,877 Director 7,500 2011-11-17 Filing
INCY $13.41 2,338 Director 3,623 2011-11-17 Filing
INCY $13.37 700 Director 1,285 2011-11-17 Filing
INCY $13.39 585 Director 585 2011-11-17 Filing